RxDoctor Payments Data

Pavan Jhaveri, MD

Radiation Oncology · Kingwood, TXNPI 1285895136

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $11,000 of the $16,445 with a category attached, or 66.9%. Novocure Inc. accounts for 88.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $11,151 and has fallen 98.9% since, to $118 in 2025. Among radiation oncology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,445in general payments, 2019–2025

Across 34 payments — averaging $483.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novocure Inc.$15K
  • Accuray Incorporated$1K
  • Boston Scientific$241
  • Brainlab, Inc.$98
  • Viewray Technologies Inc$35
  • Siemens Medical Solutions USA, Inc.$20

What the payments were for

  • Consulting fees$3,40021%
  • Speaking & faculty fees$11,00067%
  • Travel & lodging$1,2327%
  • Food & beverage$8135%

General payments by program year

20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,445 in reported general payments places this provider in the 90th percentile of 418 radiation oncology providers in Texas.

See all radiation oncology providers in Texas →

Medicare billing

Part B allowed, 2024
$49,452
Medicare patients
52
Services billed
546

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Kingwood

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →